NCT01304043

Brief Summary

To take charge of the treatment in rare adult ovarian tumors with an homogenous manner (germinal and sexual cords tumors), at different stages of the disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
204

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2002

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2002

Completed
3.7 years until next milestone

First Submitted

Initial submission to the registry

September 9, 2005

Completed
5.5 years until next milestone

First Posted

Study publicly available on registry

February 25, 2011

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2011

Completed
Last Updated

April 20, 2012

Status Verified

April 1, 2012

First QC Date

September 9, 2005

Last Update Submit

April 19, 2012

Conditions

Ovarian Tumors

Keywords

ovarian tumorsrare ovarian tumorsgerminal tumorssexual cords tumorsobservatoryforum

Interventions

chemotherapies protocolsDRUG

Cisplatine 20 mg/m² IV Etoposide 100 mg/m² IV Bléomycine 30 mg IV

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

female with rare ovarian cancer

You may qualify if:

  • age \> 18 years old
  • germinal or sexual cords ovary tumors histologically proven
  • first line or relapse treatment
  • written informed consent

You may not qualify if:

  • mental ineptitude to understand and follow the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oncologie, Hôtel-Dieu, 1 place du parvis Notre-Dame

Paris, 75004, France

Location

Related Links

MeSH Terms

Conditions

Ovarian Neoplasms

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Neoplasms, FemaleUrogenital NeoplasmsGenital DiseasesEndocrine System DiseasesGonadal Disorders

Study Officials

  • Isabelle Ray-Coquard, Physician

    GINECO

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 9, 2005

First Posted

February 25, 2011

Study Start

January 1, 2002

Study Completion

June 1, 2011

Last Updated

April 20, 2012

Record last verified: 2012-04

Locations

FR(1)